Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey. Issue 153 (May 2017)

• Record Type: Journal Article
• Authors: Chaturvedi, Shruti; Clancy, Marianne; Schaefer, Nicole; Oluwole, Olalekan; McCrae, Keith R.
• Is Part Of: Thrombosis research. Issue 153(2017)
• Page Start: 14
• Page End: 18
• Publication Date: 2017-05
• Subjects: HHT hereditary hemorrhagic telangiectasia -- PTSD post-traumatic stress disorder -- DSM-5 Diagnostic and statistical manual of mental disorders -- PCL-5 Post-traumatic stress disorder checklist for DSM-5 -- BDI-II Beck Depression Inventory II -- OR Odds ratio -- IQR interquartile range; Hereditary hemorrhagic telangiectasia -- Post-traumatic stress disorder -- Depression -- Quality of life -- Bleeding disorder other than hemophilia -- Epistaxis; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2017.03.003
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Introduction: Hereditary hemorrhagic telangiectasia (HHT) is characterized by frequent severe bleeding, particularly epistaxis, and life-threatening complications including stroke, brain abscess and heart failure. The psychological impact of HHT is not known. We conducted this cross sectional study to determine the prevalence of depression and post-traumatic stress disorder (PTSD) related to HHT. Methods: A survey tool comprising demographic and clinical information and two validated self-administered questionnaires, the PTSD checklist for DSM-5 (PCL-5) and Beck Depression Inventory-II (BDI-II), was distributed to individuals with HHT. Associations with clinical and demographic variables with depression and PTSD were evaluated in a logistic regression model. Results: A total of 222 individuals responded to the survey. Of these, 185 completed either the BDI II or PCL-5 and were included in the analysis. Median age was 54 years and 142 (76.8%) were female. An existing diagnosis of depression, anxiety disorder and PTSD was present in 81 (43.8%), 59 (31.9%) and 16(8.6%) respondents, respectively. BDI-II scores > 13 indicating at least mild depressive symptoms were present in 142 (88.7%) patients and 52 (28.1%) patients had a positive screen for PTSD (PCL-5 score ≥ 38). On multivariable analysis, depression [OR 2.17 (95% CI 1.045–4.489), p = 0.038], anxiety disorder [OR 2.232 (95% CI 1.066–4.676), p = 0.033], and being unemployed [OR 2.234 (95% CI 1.46–4.714), p = 0.019) were associated with PTSD. Conclusion: We report a high prevalence of depressive and PTSD symptoms in individuals with HHT. While selection bias may lead to overestimation of prevalence in this study, our results are concerning and clinicians should remain vigilant for signs of psychological distress and consider screening for these disorders. Highlights: There is a high prevalence of depressive (88.7%) and post-traumatic stress disorder (28.1%) symptoms in individuals with HHT. Many individuals with HHT are able to identify a traumatic event related to their disease that caused psychological distress. Identifying and treating depression and PTSD may improve quality of life in individuals with HHT. Further studies are required to evaluate the psychological impact of living with a chronic hematologic disorder such as HHT.